Ruthenium and platinum-based anticancer metallotherapeutics from the perspectives of photodynamic therapy and bioimaging applications DOI

Sowmiya Ganesan,

Angappan Sheela

Chemical Papers, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 26, 2024

Language: Английский

A prospective therapeutic strategy: GPX4-targeted ferroptosis mediators DOI

Jia-Yu Qian,

Chao-Yuan Lou,

Yili Chen

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 281, P. 117015 - 117015

Published: Oct. 30, 2024

Language: Английский

Citations

2
ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer DOI
Bei-bei Zhang, Hao Liu, Yifei Wang

et al.

ACS Biomaterials Science & Engineering, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 12, 2024

Ferroptosis is an appealing cancer therapy strategy based on the H

Language: Английский

Citations

1
A Potent and Selective Anti-Glutathione Peroxidase 4 Nanobody as Ferroptosis Inducer DOI Creative Commons
Xinyu Li, Yaru Li, Aowei Xie

et al.

Chemical Science, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

Glutathione peroxidase 4 (GPX4) plays a crucial role in the ferroptosis pathway, emerging as potential drug target treatment of refractory tumors.

Language: Английский

Citations

1
Ruthenium and platinum-based anticancer metallotherapeutics from the perspectives of photodynamic therapy and bioimaging applications DOI

Sowmiya Ganesan,

Angappan Sheela

Chemical Papers, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 26, 2024

Language: Английский

Citations

0